CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,789 | -2.0% | 16,483 | -12.9% | 0.00% | – |
| Q2 2023 | $80,423 | -76.2% | 18,923 | -70.3% | 0.00% | -100.0% |
| Q1 2023 | $338,374 | -16.7% | 63,724 | -1.5% | 0.00% | 0.0% |
| Q4 2022 | $406,102 | -39.7% | 64,666 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $674,000 | +93.1% | 63,926 | -0.6% | 0.00% | 0.0% |
| Q2 2022 | $349,000 | -9.8% | 64,294 | +52.6% | 0.00% | 0.0% |
| Q1 2022 | $387,000 | -18.5% | 42,132 | +33.8% | 0.00% | 0.0% |
| Q4 2021 | $475,000 | +92.3% | 31,489 | +203.9% | 0.00% | – |
| Q3 2021 | $247,000 | – | 10,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $2,266,040 | 15.18% |
| Elmwood Wealth Management, Inc. | 2,364,415 | $11,301,904 | 5.45% |
| PFM Health Sciences, LP | 6,724,715 | $32,144,138 | 1.51% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 892,786 | $4,267,517 | 1.29% |
| Avidity Partners Management LP | 6,050,212 | $28,920,013 | 1.16% |
| Paradigm Biocapital Advisors LP | 2,944,513 | $14,074,772 | 0.96% |
| Kynam Capital Management, LP | 1,068,527 | $5,107,559 | 0.84% |
| Green Alpha Advisors, LLC | 110,524 | $528,305 | 0.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,500,000 | $16,730,000 | 0.37% |
| Bruce & Co., Inc. | 200,000 | $956,000 | 0.33% |